Table 5 Correlation between the change in serum CA125 and the objective response
From: Clinical significance of serum CA125 in diffuse malignant mesothelioma
No. | Baseline CA125 | CA125 after systemic CT | Change (U/ml) | Response |
|---|---|---|---|---|
1 | 10.19 | 12.74 | 2.55 | SD |
2 | 15.10 | 8.62 | −6.48 | SD |
3 | 17.07 | 42.34 | 25.27 | PD |
4 | 30.67 | 5.00 | −25.67 | PR |
5 | 53.52 | 58.67 | 5.15 | PD |
6 | 75.14 | 16.45 | −58.69 | SD |
7 | 75.94 | 136.90 | 60.96 | SD |
8 | 138.60 | 10.11 | −128.49 | SD |
9 | 176.20 | 161.90 | −14.30 | SD |
10 | 519.40 | 229.90 | −289.50 | SD |
11 | 615.90 | 6.70 | −609.20 | PR |
12 | 1918.00 | 462.90 | −1455.10 | PR |